Abstract
Frequencies of the 5382insC mutation in the BRCA1 gene and the 1100delC mutation in the CHEK2 gene were compared in the group of breast cancer patients and the large-scale sample, consisting of 7920 DNA specimens from healthy residents of the city of Novosibirsk. Higher frequencies of these mutations in the patient group compared to the control sample (1.95% versus 0.25% for BRCA1 5382insC, and 1.78% versus 0.40% for CHEK2 1100delC) were observed, pointing to their association with susceptibility to breast cancer (OR = 7.86; 95% CI 3.51–17.30 and OR =4.46: 95% CI 2.04–9.49, respectively).
References
Gevensleben, H., Serçe, N., and Büttner, R., Hereditary Breast and Ovarian Cancers, Pathologe, 2010, vol. 31, no. 6, pp. 438–444.
Lux, M.P., Fasching, P.A., and Beckmann, M.W., Hereditary Breast and Ovarian Cancer: Review and Future Perspectives, J. Mol. Med., 2006, vol. 84, no. 1, pp. 16–28.
Meindl, A., Ditsch, N., Kast, K., et al., Hereditary Breast and Ovarian Cancer—New Genes, New Treatments, New Concepts, Dtsch. Arztebl. Int., 2011, vol. 108, no. 19, pp. 323–330.
Nevanlinna, H. and Bartek, J., The CHEK2 Gene and Inherited Breast Cancer Susceptibility, Oncogene, 2006, vol. 25, no. 43, pp. 5912–5919.
Johnson, N., Fletcher, O., Naceur-Lombardelli, C., et al., Interaction between CHEK2*1100delC and Other Low-Penetrance Breast-Cancer Susceptibility Genes: A Familial Study, Lancet, 2005, vol. 366, no. 9496, pp. 1554–1557.
Weischer, M., Bojesen, S.E., Ellervik, C., et al., CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26.000 Patient Cases and 27.000 Controls, J. Clin. Oncol., 2008, vol. 26, no. 4, pp. 542–548.
Voevoda, M.I., Kulikov, I.V., Shakhtshneider, E.V., et al., The Spectrum of Mutations in the Low-Density Lipoprotein Receptor Gene in the Russian Population, Russ. J. Genet., 2008, vol. 44, no. 10, pp. 1191–1194.
Mitrofanov, D.V., Chasovnikova, O.B., Kovalenko, S.P., and Lyakhovich, V.V., Detection of the 5382insC Mutation in the Human BRCA1 Gene with Fluorescent Labeled Oligonucleotides, Mol. Biol. (Moscow), 2009, vol. 43, no. 6, pp. 930–936.
Yang, L., Liang, W., Jiang, L., et al., A Novel Universal Real-Time PCR System Using the Attached Universal Duplex Probes for Quantitative Analysis of Nucleic Acids, BMC Mol. Biol., 2008, vol. 9, pp. 54–66.
Neuhausen, S.L., Founder Populations and Their Uses for Breast Cancer Genetics, Breast Cancer Res., 2000, vol. 2, no. 2, pp. 77–81.
Gorski, B., Cybulski, C., Huzarski, T., et al., Breast Cancer Predisposing Alleles in Poland, Breast Cancer Res. Treat., 2005, vol. 92, no. 1, pp. 19–24.
Pohlreich, P., Zikan, M., Stribrna, J., et al., High Proportion of Recurrent Germline Mutations in the BRCA1 Gene in Breast and Ovarian Cancer Patients from the Prague Area, Breast Cancer Res., 2005, vol. 7, no. 5, pp. 728–736.
Ladopoulou, A., Kroupis, C., Konstantopoulou, I., et al., Germ Line BRCA1 and BRCA2 Mutations in Greek Breast/Ovarian Cancer Families: 5382insC Is the Most Frequent Mutation Observed, Cancer Lett., 2002, vol. 185, no. 1, pp. 61–70.
Tikhomirova, L., Sinicka, O., Smite, D., et al., High Prevalence of Two BRCA1 Mutations, 4154delA and 5382insC, in Latvia, Fam. Cancer, 2005, vol. 4, no. 2, pp. 77–84.
Lubin’ski, B., Gor’ski, B., Huzarski, T., et al., BRCA1-Positive Breast Cancers in Young Women from Poland, Breast Cancer Res. Treat., 2006, vol. 99, no. 1, pp. 71–76.
Sokolenko, A.P., Rozanov, M.E., Mitiushkina, N.V., et al., Founder Mutations in Early-Onset, Familial and Bilateral Breast Cancer Patients from Russia, Fam. Cancer, 2007, vol. 6, no. 3, pp. 281–286.
Imyanitov, E.N., Hereditary Breast Cancer, Prakt. Onkol., 2010, vol. 11, no. 4, pp. 258–266.
Fedorova, O.E., Sinitska, O.N., Tikhomirova, L.P., et al., Analysis of Point Mutations in BRCA1 Gene Using Hybridization on Hydrogel Microchips, Mol. Biol. (Moscow), 2006, vol. 40, pp. 31–36.
Loginova, A.N., Pospekhova, N.I., Lyubchenko, L.N., et al., Spectrum of Mutations in BRCA1 Gene in Hereditary Forms of Breast and Ovarian Cancer in Russian Families, Byull. Eksp. Biol. Med., 2003, vol. 136, no. 3, pp. 315–317.
Sokolenko, A.P., Mitiushkina, N.V., Buslov, K.G., et al., High Frequency of BRCA1 5382insC Mutation in Russian Breast Cancer Patients, Eur. J. Cancer, 2006, vol. 42, no. 10, pp. 1380–1384.
Imyanitov, E.N., Molecular Diagnosis in Oncology, Mol. Biol. (Moscow), 2008, vol. 42, no. 5, pp. 687–698.
Chekmariova, E.V., Sokolenko, A.P., Buslov, K.G., et al., CHEK2 1100delC Mutation Is Frequent among Russian Breast Cancer Patients, Breast Cancer Res. Treat., 2006, vol. 100, no. 1, pp. 99–102.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © O.B. Chasovnikova, D.V. Mitrofanov, M.S. Anisimenko, M.I. Voevoda, S.P. Kovalenko, V.V. Lyakhovich, 2012, published in Genetika, 2012, Vol. 48, No. 6, pp. 768–772.
Rights and permissions
About this article
Cite this article
Chasovnikova, O.B., Mitrofanov, D.V., Anisimenko, M.S. et al. Prevalence of mutations BRCA1 5382insC, and CHEK2 1100delC in the population of Siberian region. Russ J Genet 48, 656–659 (2012). https://doi.org/10.1134/S1022795412040047
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795412040047